SubHero Banner
Text

Firdapse® (amifampridine) – New orphan drug approval

November 28, 2018 - The FDA announced the approval of Catalyst Pharmaceutical’s Firdapse (amifampridine), for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

Download PDF